Moreover, studies investigating their use as therapeutic targets, such as by administrating TLR7 inhibitors or by inducing CD95‐mediated apoptosis, may reveal valid therapeutic strategies for SLE. This evidence concerns the gene FAS and systemic lupus erythematosus.